Free Trial
NASDAQ:JMAC

Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Maxpro Capital Acquisition logo
$6.61 +0.07 (+1.14%)
As of 05/28/2025

About Maxpro Capital Acquisition Stock (NASDAQ:JMAC)

Key Stats

Today's Range
$6.04
$6.61
50-Day Range
$4.89
$9.90
52-Week Range
$7.50
$19.22
Volume
3,079 shs
Average Volume
74,040 shs
Market Capitalization
$88.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Receive JMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maxpro Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JMAC Stock News Headlines

Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
Maxpro Capital Acquisition Corp
See More Headlines

JMAC Stock Analysis - Frequently Asked Questions

Maxpro Capital Acquisition's stock was trading at $9.75 on January 1st, 2025. Since then, JMAC shares have decreased by 32.9% and is now trading at $6.54.
View the best growth stocks for 2025 here
.

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), PhaseBio Pharmaceuticals (PHAS), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI), Centogene (CNTG) and China Jo-Jo Drugstores (CJJD).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JMAC
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
10,840,000
Market Cap
$88.82 million
Optionable
Not Optionable
Beta
0.01
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:JMAC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners